Today is Monday, June 1, 2026.
The Early Bird Index today is 90.91.
New to this newsletter? Sign up here
The AI Chip Loophole Is Over 🚨
A blockbuster geopolitical guidance was issued on Sunday, one that could potentially impact Nvidia $NVDA ( ▼ 1.45% ) and AMD $AMD ( ▼ 0.38% ) going forward.
Details: The United States Department of Commerce announced plans to close a potential loophole that allowed the export of artificial intelligence chips to Chinese-headquartered companies with subsidiaries located outside China.
Background: The U.S. government enforces strict controls and export bans on advanced AI chips to China, including chips from Nvidia and AMD. This new guidance would extend those controls to Chinese entities with operations located outside China.
Early Bird’s Nest Egg Gains: For Nvidia and AMD, this new guidance likely means fewer chip shipments to China-linked buyers outside China, more licensing friction and possible shipment delays, and less leakage of top-end accelerators into Chinese AI buildouts.
Nvidia is more exposed because it has a larger AI chip franchise, and the most valuable high-end parts appear to be in scope.
AMD is also exposed, but usually less so than Nvidia because its AI accelerator business is smaller and the market’s expectations are lower.
Final Thoughts: While Nvidia’s stock is up 11% this year, AMD’s stock has surged by 130%.
PRESENTED BY BLINKLAB
Could a Smartphone Help Diagnose Autism?
BlinkLab Limited (ASX: BB1) is developing an AI-powered smartphone platform designed to help clinicians diagnose autism faster and more objectively.
📱 Right now, autism diagnosis can take years, cost thousands of dollars, and requires access to a limited number of specialists. BlinkLab's technology uses a smartphone camera to analyze tiny facial reflexes, eye movements, and behavioral responses that may serve as digital biomarkers for autism.
📊 In a 485-patient U.S. pilot study, BlinkLab reported:
• 83.7% sensitivity
• 84.7% specificity
Both results exceeded the FDA's minimum clearance benchmark of 65%, according to the company.
🏥 The company has now launched its FDA 510(k) pivotal study across 10 leading U.S. autism research centers, with FDA submission targeted for Q4 2026.
🌎 BlinkLab was also selected for a Moroccan government-backed autism screening initiative that aims to reach up to 600,000 children annually across 3,000 centers.
🧠 Backed by an exclusive Princeton University IP license, BlinkLab is developing what could become a scalable digital diagnostic platform for autism, ADHD, and other neurological conditions.
This content was produced on behalf of BlinkLab Limited ( BB1) and sponsored by the company. The influencer was compensated by Cashu Group to create this content. This is not financial advice, and viewers are encouraged to consult a financial professional before making investment decisions. Investing in companies involves significant risks, and past performance does not guarantee future results. Please do your own research.
Notables
Notable Earnings Today: Hewlett Packard Enterprise (NYSE: HPE), Science Applications (Nasdaq: SAIC), Credo Technology Group (Nasdaq: CRDO).
Notable IPOs Today: Liberty Latin America Ltd Class A Common Stock Ex-Distribution When Issued (Nasdaq: LILAV), Liberty Latin America Ltd Class C Common Stock Ex-Distribution When Issued (Nasdaq: LILKV).
Notable Equity Crowdfunding Campaigns Ending Today: Tatleaux - NJ Community Solar (Honeycomb), Creature Comforts ADK (Honeycomb).
Notable Economic Events Today: S&P Global Manufacturing PMI (9:45 a.m. ET), ISM Manufacturing PMI / Prices / Employment (10:00 a.m. ET), Construction Spending (10:00 a.m. ET).
Hyperliquid's Strong May
As most major cryptocurrency prices fell in May, Hyperliquid $HYPE ( ▲ 8.48% ) experienced a strong price boost. On Sunday, Hyperliquid gained another 5%.
Details: Hyperliquid is up 17% in the past week and up 76% in May.
Powering the Story: The token’s price was being pulled up by a very powerful demand loop: real exchange revenue, aggressive protocol buybacks, and fresh institutional buying through new spot HYPE products.
Final Thoughts: Hyperliquid is one of the few major cryptos to go up in price in 2026.
Johnson & Johnson's Prostate Cancer Drug Results
On Sunday, Johnson & Johnson $JNJ ( ▼ 2.37% ) reported that its prostate cancer drug, Erleada, produced good results in phase 3 trials.
Details: Patients given the drug for six months before and after prostate cancer surgery showed improved outcomes.
Final Thoughts: Johnson & Johnson’s stock is up 8.67% this year.
Trends to Watch
Waiting on a Big Week: Bond Trader Bets on Fed Hike Poised for Gut Check From Jobs Data (Bloomberg)
Flight or Flight Mode: United Airlines flight to Spain pulls U-turn, apparently over Bluetooth device name (NPR)
First Takeover Since Buffett’s Exit: Berkshire Hathaway to buy Taylor Morrison for $8.5 billion in housing push (CNNC)
Mandate Debate: This $50,000 Safety Fix Is Dividing the Aviation Industry and Washington (Wall Street Journal)
Late May Slump: Bitcoin preps 3% May downside, but US PMI data may boost BTC price (Cointelegraph)
Thank you for reading!
Forward to a friend and tell them to sign up here.
Pick winning stocks: Upgrade to Early Bird Prime.
Become a smarter investor: Get Early Bird Exclusives
Want more investing tips? Listen to the podcast.
Show Your Support: Buy Me a Coffee.
Questions or comments? Hit reply to reach out.
The contents of Early Bird are intended for informational and entertainment purposes only. They do not constitute trade or investment recommendations, and they are not financial or legal advice. Readers are encouraged to consult licensed professionals for personalized guidance regarding their financial or legal situations.
